AVITA Medical Inc [RCEL] stock is trading at $4.34, down -0.91%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RCEL shares have lost -11.07% over the last week, with a monthly amount drifted -18.11%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
AVITA Medical Inc [NASDAQ: RCEL] stock has seen the most recent analyst activity on August 08, 2025, when BTIG Research downgraded its rating to a Sell but kept the price target unchanged to $3 for it. Previously, D. Boral Capital started tracking the stock with Buy rating on December 24, 2024, and set its price target to $25. On April 11, 2024, downgrade downgraded it’s rating to Neutral. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $23 on June 27, 2023. Piper Sandler initiated its recommendation with a Overweight and recommended $27 as its price target on March 02, 2021. BofA Securities started tracking with a Buy rating for this stock on August 27, 2020, and assigned it a price target of $42. In a note dated April 21, 2020, Oppenheimer initiated an Outperform rating and provided a target price of $9 on this stock.
AVITA Medical Inc [RCEL] stock has fluctuated between $3.60 and $14.16 over the past year. Currently, Wall Street analysts expect the stock to reach $11.5 within the next 12 months. AVITA Medical Inc [NASDAQ: RCEL] shares were valued at $4.34 at the most recent close of the market. An investor can expect a potential return of 164.98% based on the average RCEL price forecast.
Analyzing the RCEL fundamentals
AVITA Medical Inc [NASDAQ:RCEL] reported sales of 74.88M for the trailing twelve months, which represents a growth of 21.21%. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -0.62%, Pretax Profit Margin comes in at -0.69%, and Net Profit Margin reading is -0.69%. To continue investigating profitability, this company’s Return on Assets is posted at -0.89, Equity is 279.91 and Total Capital is 10.46. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -3.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.20 points at the first support level, and at 4.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.55, and for the 2nd resistance point, it is at 4.77.
Ratios To Look Out For
For context, AVITA Medical Inc’s Current Ratio is 0.58. Also, the Quick Ratio is 0.46, while the Cash Ratio stands at 0.2. Considering the valuation of this stock, the price to sales ratio is 1.44.
Transactions by insiders
Recent insider trading involved McNamara Robert, Director, that happened on Aug 28 ’25 when 10000.0 shares were purchased. CFO, O’Toole David D completed a deal on Aug 26 ’25 to buy 2000.0 shares. Meanwhile, Director McNamara Robert bought 10000.0 shares on Aug 19 ’25.
